Nearly a dozen biotechnology firms have matched or raised more than $300 million in their initial public offerings in 2026, a figure not seen since new stock sales peaked in 2021. In the first biotech ...

Electra plans to use the proceeds to continue developing an experimental drug for secondary hemophagocytic lymphohistiocytosis or "HLH," a rare, sometimes life-threatening immune disorder with no ...

Electra plans to develop its EL9 Ultra Short, a nine-passenger hybrid-electric aircraft designed for short take-off/landing in minimal spaces, targeting commercial service by 2030. The company ...

Electra Therapeutics has unveiled that it plans to raise up to $341.9m in an initial public offering (IPO), with the funds expected to power Phase III development for its hyperinflammatory syndrome ...

Electra Therapeutics (ETRA), a developer of antibody therapies for immune-mediated conditions and cancer, upsized its U.S. initial public offering ahead of its trading debut on Friday, expecting to ...

Electra Therapeutics has exceeded its initial fundraising plans as it becomes the 26th biotech to debut publicly this year and outlines pivotal development plans for its monoclonal antibody ...

The IPO funds will be added to the $97.7 million that Electra was sitting on at the end of June. (Rene Notenbomer/iStock/Getty Images Plus) Electra Therapeutics is the latest biotech to overshoot its ...

Electra Callan has been advising clients on private equity transactions for over a decade; covering competitive and proprietary M&A transactions, the deployment of buy and build strategies and ...

Electra ISD is a community school district in North Texas in Wichita County. As of the most recent enrollment data released by the state, its student population was 67.9% white and 62.7% economically ...